Most commonly used treatment for hemochromatosis is a procedure to remove some of your blood, known as a phlebotomy or venesection. The procedure is similar to giving blood. You lie back in a chair and a needle is used to drain a small amount of blood, usually about 500ml, from a vein in your arm.
Identifying and managing hereditary hemochromatosis in adults
Hereditary hemochromatosis is the most common genetic disease in European populations. It is an autosomal recessive disorder which leads to elevated iron absorption. This in turn can lead to iron deposition in tissue which adversely influences organ function, leading to a range of complications, such as arthralgia, diabetes, heart disease, liver cirrhosis and hepatocellular carcinoma. Patients who have biochemical evidence of abnormal iron metabolism, measured by ferritin levels and transferrin saturation, require genetic testing after excluding non-specific causes of ferritin elevation. Treatment of hemochromatosis aims to reduce body iron stores by regular venesection until target ferritin levels are reached. Venesection reduces the risk of some complications, but not others, and continued monitoring of iron levels and possible clinical consequences is necessary.
Symptoms.
Symptoms of hemochromatosis usually begin between the ages of 30 and 60, although they can occur earlier.
The symptoms tend to develop earlier in men than in women. Women often do not experience problems until after the menopause.
Sometimes there are no symptoms and the condition is only found during a blood test.
Early symptoms
Initial symptoms of hemochromatosis can include:
feeling very tired all the time (fatigue)
weight loss
weakness
joint pain
an inability to get or maintain an erection (erectile dysfunction)
irregular periods or absent periods
These symptoms can have many different causes and may sometimes just be because of getting older.
Later problems
As the condition progresses, it can also cause problems such as:
loss of sex drive (libido)
darkening of the skin, if you are white – you may look permanently tanned
tummy (abdominal) pain and swelling
yellowing of the skin and eyes (jaundice)
feeling thirsty all the time and needing to pee frequently
severe pain and stiffness in your joints, particularly in the fingers
chest pain
shortness of breath
swelling of your hands and feet
an irregular heartbeat (arrhythmia)
the testicles getting smaller
These problems are often caused by complications of hemochromatosis that can happen if the condition is not treated early on.
Causes.
Hemochromatosis is caused by a faulty gene that can be passed on to a child by their parents.
Most cases are linked to a fault in a gene called HFE, which affects your ability to absorb iron from food.
Normally, your body maintains a steady level of iron. The amount of iron absorbed from food varies according to your body's need for it.
But people with hemochromatosis cannot control their iron level. The level gradually increases over time and iron starts to build up in their organs, damaging them in the process.
Hemochromatosis is usually a hereditary condition, characterised by increased iron absorption leading to iron deposition in tissues and ultimately organ damage. Iron is an essential mineral in the diet. It is a key constituent of haemoglobin and helps regulate a number of biological processes involved in the immune response, oxygen transport and the function of various enzymes in the body, including the hepatic cytochrome enzymes. The average person has around three to four grams of iron in their body.1 As there is no control mechanism for iron excretion in humans, iron stores in the body are regulated by controlling iron absorption; a key hormone involved is hepcidin, which is released by the liver and acts on duodenal cells to inhibit iron absorption.
In 1996 it was discovered that approximately 80% – 85% of cases of hereditary hemochromatosis are caused by common variants of the HFE gene.2, 3 Although the molecular mechanism is not clear, these common variants increase the chances of low hepatic production of hepcidin, leading to increased iron absorption. People with this form of hemochromatosis are referred to as having HFE hereditary hemochromatosis (HFE-HH). However, the condition is recessive and people who inherit only one copy of identified genetic risk factors will not develop clinical disease. Iron accumulation in people with HFE-HH is usually not evident until adulthood.
The prevalence of hereditary hemochromatosis in New Zealand is unknown, but a study of over 1000 people in Christchurch (predominantly Caucasian) found that 38.4% of the population had at least one copy of a risk allele; however, only 0.28%, or one in 355, had hemochromatosis requiring treatment.4
Who is most at risk?
A patient’s ethnicity is a key feature to consider when assessing their risk of hereditary hemochromatosis, and sex is a risk factor for developing clinical complications.
Blood tests
The two key tests to detect iron overload are:
Serum transferrin saturation. This test measures the amount of iron bound to a protein (transferrin) that carries iron in your blood. Transferrin saturation values greater than 45% are considered too high.
Serum ferritin. This test measures the amount of iron stored in your liver. If the results of your serum transferrin saturation test are higher than normal, your doctor will check your serum ferritin.
Because a number of other conditions can also cause elevated ferritin, both blood tests are typically abnormal among people with this disorder and are best performed after you have been fasting. Elevations in one or all of these blood tests for iron can be found in other disorders. You may need to have the tests repeated for the most accurate results.
Additional testing
Your doctor may suggest other tests to confirm the diagnosis and to look for other problems:
Liver function tests. These tests can help identify liver damage.
MRI. An MRI is a fast and noninvasive way to measure the degree of iron overload in your liver.
Testing for gene mutations. Testing your DNA for mutations in the HFE gene is recommended if you have high levels of iron in your blood. If you're considering genetic testing for hemochromatosis, discuss the pros and cons with your doctor or a genetic counselor.
Removing a sample of liver tissue for testing (liver biopsy). If liver damage is suspected, your doctor may have a sample of tissue from your liver removed, using a thin needle. The sample is sent to a laboratory to be checked for the presence of iron as well as for evidence of liver damage, especially scarring or cirrhosis. Risks of biopsy include bruising, bleeding and infection.
Screening healthy people for hemochromatosis
Genetic testing is recommended for all first-degree relatives — parents, siblings and children — of anyone diagnosed with hemochromatosis. If a mutation is found in only one parent, then children do not need to be tested.
Treatment of Hemochromatosis
How do doctors treat hemochromatosis?
In most cases, doctors treat hemochromatosis with phlebotomy, or drawing about a pint of blood at a time, on a regular schedule. This is the most direct and safe way to lower body stores of iron NIH external link.
Treatment of hemochromatosis can improve symptoms and prevent complications.
Phlebotomy
Phlebotomy removes extra iron from your blood. Phlebotomy is simple, inexpensive, and safe.
How much blood is drawn and how often depends on your iron levels. Doctors usually start by having a pint of blood drawn once or twice a week for several months. Doctors will order regular blood tests to check iron and ferritin NIH external link levels.
Phlebotomy is usually done in blood banks just like routine blood donation NIH external link. In some cases, blood drawn from people with hemochromatosis may be donated and used in people who need blood transfusions NIH external link.
After phlebotomy has removed extra iron and blood levels of iron and ferritin return to normal, doctors will reduce phlebotomies to once every 1 to 3 months and eventually to 2 to 3 times a year. Doctors will continue to order regular blood tests to check iron and ferritin levels.
Other treatments
People who receive blood transfusions to treat certain types of anemia and develop secondary hemochromatosis cannot have phlebotomy to lower their iron levels. To treat secondary hemochromatosis in these people, doctors prescribe medicines, called chelating agents, that bind to iron and allow it to pass from the body in urine. Chelating agents may be pills taken by mouth or intravenous (IV) medicines, and they do not remove iron as effectively as phlebotomy.
Doctors treat neonatal hemochromatosis in newborns with exchange transfusions—removing blood and replacing it with donor blood—and IV immunoglobulin—a solution of antibodies from healthy people. These treatments do not always work to reverse severe liver damage, and a liver transplant may be needed. Often the newborn’s mother or father can serve as a living liver donor. Only a small part of the adult donor liver is needed for transplantation into a newborn.
Keywords
Hemochromatosis-Treatment Symptoms.
Most commonly used treatment for hemochromatosis is a procedure to remove some of your blood, known as a phlebotomy or venesection. The procedure is similar to giving blood. You lie back in a chair and a needle is used to drain a small amount of blood, usually about 500ml, from a vein in your arm.
Identifying and managing hereditary hemochromatosis in adults
Hereditary hemochromatosis is the most common genetic disease in European populations. It is an autosomal recessive disorder which leads to elevated iron absorption. This in turn can lead to iron deposition in tissue which adversely influences organ function, leading to a range of complications, such as arthralgia, diabetes, heart disease, liver cirrhosis and hepatocellular carcinoma. Patients who have biochemical evidence of abnormal iron metabolism, measured by ferritin levels and transferrin saturation, require genetic testing after excluding non-specific causes of ferritin elevation. Treatment of hemochromatosis aims to reduce body iron stores by regular venesection until target ferritin levels are reached. Venesection reduces the risk of some complications, but not others, and continued monitoring of iron levels and possible clinical consequences is necessary.
Symptoms.
Symptoms of hemochromatosis usually begin between the ages of 30 and 60, although they can occur earlier.
The symptoms tend to develop earlier in men than in women. Women often do not experience problems until after the menopause.
Sometimes there are no symptoms and the condition is only found during a blood test.
Early symptoms
Initial symptoms of hemochromatosis can include:
feeling very tired all the time (fatigue)
weight loss
weakness
joint pain
an inability to get or maintain an erection (erectile dysfunction)
irregular periods or absent periods
These symptoms can have many different causes and may sometimes just be because of getting older.
Later problems
As the condition progresses, it can also cause problems such as:
loss of sex drive (libido)
darkening of the skin, if you are white – you may look permanently tanned
tummy (abdominal) pain and swelling
yellowing of the skin and eyes (jaundice)
feeling thirsty all the time and needing to pee frequently
severe pain and stiffness in your joints, particularly in the fingers
chest pain
shortness of breath
swelling of your hands and feet
an irregular heartbeat (arrhythmia)
the testicles getting smaller
These problems are often caused by complications of hemochromatosis that can happen if the condition is not treated early on.
Causes.
Hemochromatosis is caused by a faulty gene that can be passed on to a child by their parents.
Most cases are linked to a fault in a gene called HFE, which affects your ability to absorb iron from food.
Normally, your body maintains a steady level of iron. The amount of iron absorbed from food varies according to your body's need for it.
But people with hemochromatosis cannot control their iron level. The level gradually increases over time and iron starts to build up in their organs, damaging them in the process.
Hemochromatosis is usually a hereditary condition, characterised by increased iron absorption leading to iron deposition in tissues and ultimately organ damage. Iron is an essential mineral in the diet. It is a key constituent of haemoglobin and helps regulate a number of biological processes involved in the immune response, oxygen transport and the function of various enzymes in the body, including the hepatic cytochrome enzymes. The average person has around three to four grams of iron in their body.1 As there is no control mechanism for iron excretion in humans, iron stores in the body are regulated by controlling iron absorption; a key hormone involved is hepcidin, which is released by the liver and acts on duodenal cells to inhibit iron absorption.
In 1996 it was discovered that approximately 80% – 85% of cases of hereditary hemochromatosis are caused by common variants of the HFE gene.2, 3 Although the molecular mechanism is not clear, these common variants increase the chances of low hepatic production of hepcidin, leading to increased iron absorption. People with this form of hemochromatosis are referred to as having HFE hereditary hemochromatosis (HFE-HH). However, the condition is recessive and people who inherit only one copy of identified genetic risk factors will not develop clinical disease. Iron accumulation in people with HFE-HH is usually not evident until adulthood.
The prevalence of hereditary hemochromatosis in New Zealand is unknown, but a study of over 1000 people in Christchurch (predominantly Caucasian) found that 38.4% of the population had at least one copy of a risk allele; however, only 0.28%, or one in 355, had hemochromatosis requiring treatment.4
Who is most at risk?
A patient’s ethnicity is a key feature to consider when assessing their risk of hereditary hemochromatosis, and sex is a risk factor for developing clinical complications.
Blood tests
The two key tests to detect iron overload are:
Serum transferrin saturation. This test measures the amount of iron bound to a protein (transferrin) that carries iron in your blood. Transferrin saturation values greater than 45% are considered too high.
Serum ferritin. This test measures the amount of iron stored in your liver. If the results of your serum transferrin saturation test are higher than normal, your doctor will check your serum ferritin.
Because a number of other conditions can also cause elevated ferritin, both blood tests are typically abnormal among people with this disorder and are best performed after you have been fasting. Elevations in one or all of these blood tests for iron can be found in other disorders. You may need to have the tests repeated for the most accurate results.
Additional testing
Your doctor may suggest other tests to confirm the diagnosis and to look for other problems:
Liver function tests. These tests can help identify liver damage.
MRI. An MRI is a fast and noninvasive way to measure the degree of iron overload in your liver.
Testing for gene mutations. Testing your DNA for mutations in the HFE gene is recommended if you have high levels of iron in your blood. If you're considering genetic testing for hemochromatosis, discuss the pros and cons with your doctor or a genetic counselor.
Removing a sample of liver tissue for testing (liver biopsy). If liver damage is suspected, your doctor may have a sample of tissue from your liver removed, using a thin needle. The sample is sent to a laboratory to be checked for the presence of iron as well as for evidence of liver damage, especially scarring or cirrhosis. Risks of biopsy include bruising, bleeding and infection.
Screening healthy people for hemochromatosis
Genetic testing is recommended for all first-degree relatives — parents, siblings and children — of anyone diagnosed with hemochromatosis. If a mutation is found in only one parent, then children do not need to be tested.
Treatment of Hemochromatosis
How do doctors treat hemochromatosis?
In most cases, doctors treat hemochromatosis with phlebotomy, or drawing about a pint of blood at a time, on a regular schedule. This is the most direct and safe way to lower body stores of iron NIH external link.
Treatment of hemochromatosis can improve symptoms and prevent complications.
Phlebotomy
Phlebotomy removes extra iron from your blood. Phlebotomy is simple, inexpensive, and safe.
How much blood is drawn and how often depends on your iron levels. Doctors usually start by having a pint of blood drawn once or twice a week for several months. Doctors will order regular blood tests to check iron and ferritin NIH external link levels.
Phlebotomy is usually done in blood banks just like routine blood donation NIH external link. In some cases, blood drawn from people with hemochromatosis may be donated and used in people who need blood transfusions NIH external link.
After phlebotomy has removed extra iron and blood levels of iron and ferritin return to normal, doctors will reduce phlebotomies to once every 1 to 3 months and eventually to 2 to 3 times a year. Doctors will continue to order regular blood tests to check iron and ferritin levels.
Other treatments
People who receive blood transfusions to treat certain types of anemia and develop secondary hemochromatosis cannot have phlebotomy to lower their iron levels. To treat secondary hemochromatosis in these people, doctors prescribe medicines, called chelating agents, that bind to iron and allow it to pass from the body in urine. Chelating agents may be pills taken by mouth or intravenous (IV) medicines, and they do not remove iron as effectively as phlebotomy.
Doctors treat neonatal hemochromatosis in newborns with exchange transfusions—removing blood and replacing it with donor blood—and IV immunoglobulin—a solution of antibodies from healthy people. These treatments do not always work to reverse severe liver damage, and a liver transplant may be needed. Often the newborn’s mother or father can serve as a living liver donor. Only a small part of the adult donor liver is needed for transplantation into a newborn.
Keywords
Hemochromatosis symptoms
Chelating agents
Powered By: SM and GM MANAGEMENT GROUP'S
1 Comments
Masha Allah Good effort
ReplyDelete